Erik C. Emerson - 01 Nov 2022 Form 4 Insider Report for Odyssey Health, Inc. (ODYY)

Reporting relationship: Chief Commercial Officer
Issuer ticker: ODYY
Reported as of: 01 Nov 2022
Net transaction value: +$150,000
SEC form: 4
Accepted by SEC: 23 Nov 2022, 15:02:53 UTC
Next SEC filing: 02 Jan 2024
Source filing: View source filing
Reporting owner signature: /s/ Christine M. Farrell, Attorney-in-Fact for Erik C. Emerson

Key filing fact

Erik C. Emerson filed Form 4 for Odyssey Health, Inc. (ODYY) on 23 Nov 2022.

Key facts

This page summarizes Erik C. Emerson's Form 4 filing for Odyssey Health, Inc. (ODYY).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 23 Nov 2022, 15:02.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$150,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ODYY transaction Derivative

Stock Option - Right to buy

Award

Transaction value: $31,250
Shares: +125,000
Change %
Price: $0.2500
Shares after: 125,000
Date: 01 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 125,000
Exercise price: $0.2500
Footnotes: F1

ODYY transaction Derivative

Stock Option - Right to buy

Award

Transaction value: $118,750
Shares: +475,000
Change %
Price: $0.2500
Shares after: 0
Date: 01 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 475,000
Exercise price: $0.2500
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE.